| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/1744666X.2014.968129 |
| P8608 | Fatcat ID | release_ryj6nvv275aahfojlpzuvspt6m |
| P698 | PubMed publication ID | 25300673 |
| P50 | author | Maria Gerosa | Q56985936 |
| Laura Trespidi | Q114417399 | ||
| Barbara Acaia | Q117249311 | ||
| Cecilia Beatrice Chighizola | Q38544863 | ||
| Pier Luigi Meroni | Q38544871 | ||
| P2093 | author name string | Federica Rossi | |
| Alessio Di Giacomo | |||
| P2860 | cites work | Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications | Q27027687 |
| High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin | Q28185196 | ||
| Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis | Q28190493 | ||
| Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment | Q28193717 | ||
| Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin | Q28210834 | ||
| Anti-inflammatory and immunosuppressive drugs and reproduction | Q28218219 | ||
| Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin | Q28218601 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis | Q28740531 | ||
| Clinical study and follow-up of 100 patients with the antiphospholipid syndrome | Q33331100 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| The geoepidemiology of the antiphospholipid antibody syndrome | Q33387143 | ||
| Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome | Q33393738 | ||
| Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial | Q33499382 | ||
| Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers | Q33766670 | ||
| Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
| Diagnosis of antiphospholipid syndrome in routine clinical practice | Q33939826 | ||
| The pathogenesis of the antiphospholipid syndrome | Q34332601 | ||
| Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q34788539 | ||
| A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. | Q35124036 | ||
| Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers | Q46574638 | ||
| Antiphospholipid antibodies in stillbirth | Q47128289 | ||
| The chequered history of the antiphospholipid syndrome. | Q48081474 | ||
| High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome | Q58869486 | ||
| Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. | Q35854768 | ||
| Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies | Q35977256 | ||
| Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) | Q36242479 | ||
| Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin. | Q36651142 | ||
| Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes. | Q37090069 | ||
| Predictors of pregnancy outcome in antiphospholipid syndrome: a review | Q37532018 | ||
| Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression | Q37645693 | ||
| Outcomes in women receiving low-molecular-weight heparin during pregnancy | Q37731116 | ||
| Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis | Q37760751 | ||
| Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. | Q37776132 | ||
| Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients | Q37803363 | ||
| The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis | Q37855094 | ||
| Pathogenesis of antiphospholipid syndrome: understanding the antibodies | Q37873720 | ||
| Antiphospohlipid syndrome in obstetrics | Q37955583 | ||
| Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome | Q37972052 | ||
| Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature | Q38122121 | ||
| Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? | Q38175887 | ||
| 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome | Q38197819 | ||
| Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder. | Q38211304 | ||
| Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. | Q41919391 | ||
| Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). | Q43201516 | ||
| Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome | Q43246259 | ||
| Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome | Q43801367 | ||
| Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. | Q43841492 | ||
| Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. | Q45045888 | ||
| Air pollution and hospitalization for venous thromboembolic disease in Chile | Q45083458 | ||
| Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation | Q45111033 | ||
| Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study. | Q45907237 | ||
| Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial | Q46125985 | ||
| P433 | issue | 11 | |
| P921 | main subject | pregnant person | Q104720811 |
| P304 | page(s) | 1505-1517 | |
| P577 | publication date | 2014-10-10 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome | |
| P478 | volume | 10 |
| Q33423959 | Current treatment of antiphospholipid syndrome: lights and shadows |
| Q38805695 | Does APS Impact Women's Fertility? |
| Q93060997 | Managing antiphospholipid syndrome in pregnancy |
| Q59807283 | The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome |
| Q47386457 | Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater? |
Search more.